{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:28:19Z","timestamp":1789198099254,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.diabres.2014.10.014","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T18:06:27Z","timestamp":1414173987000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Microalbuminuria: A parameter that has changed diabetes care"],"prefix":"10.1016","volume":"107","author":[{"given":"Hans-Henrik","family":"Parving","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2014.10.014_bib0005","first-page":"247","article-title":"The concomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels","volume":"118","author":"Keen","year":"1969","journal-title":"Guy's Hosp Rep"},{"key":"10.1016\/j.diabres.2014.10.014_bib0010","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/jama.1976.03270170027020","article-title":"The clinical course of diabetic nephropathy","volume":"236","author":"Kussman","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2014.10.014_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.285.6343.685","article-title":"Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy","volume":"285","author":"Mogensen","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.diabres.2014.10.014_bib0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(83)92462-5","article-title":"Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy","author":"Parving","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2014.10.014_bib0025","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","article-title":"Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus","author":"Viberti","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2014.10.014_bib0030","first-page":"550","article-title":"Early detection of patients at risk of developing diabetic nephropathy","volume":"100","author":"Parving","year":"1982","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.diabres.2014.10.014_bib0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM198407123110204","article-title":"Predicting diabetic nephropathy in insulin-dependent patients","volume":"311","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.10.014_bib0040","series-title":"Brenner and rector: the kidney","first-page":"1411","article-title":"Diabetic nephropathy","author":"Parving","year":"2012"},{"key":"10.1016\/j.diabres.2014.10.014_bib0295","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter, Suppl 2013; 3(1):5-14."},{"issue":"8","key":"10.1016\/j.diabres.2014.10.014_bib0050","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1681\/ASN.2010010063","article-title":"Comparison of different measures of urinary protein excretion for prediction of renal events","volume":"21","author":"Lambers Heerspink","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2014.10.014_bib0300","doi-asserted-by":"crossref","unstructured":"KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis 2012; 60(5):850-86.","DOI":"10.1053\/j.ajkd.2012.07.005"},{"issue":"3","key":"10.1016\/j.diabres.2014.10.014_bib0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MNH.0b013e3283456546","article-title":"Diabetic kidney disease with and without albuminuria","volume":"20","author":"MacIsaac","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.diabres.2014.10.014_bib0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ki.2014.98","article-title":"Progressive diabetic nephropathy How useful is microalbuminuria?.: contra","volume":"86","author":"MacIsaac","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.10.014_bib0070","doi-asserted-by":"crossref","first-page":"g4507","DOI":"10.1136\/bmj.g4507","article-title":"Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance","volume":"349","author":"Carville","year":"2014","journal-title":"Br Med J"},{"issue":"7","key":"10.1016\/j.diabres.2014.10.014_bib0075","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/dc09-1098","article-title":"Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study","volume":"33","author":"Molitch","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2014.10.014_bib0080","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2337\/diabetes.55.04.06.db05-1619","article-title":"Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes","volume":"55","author":"Nieuwdorp","year":"2006","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2014.10.014_bib0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00266037","article-title":"Renal changes in long-term type 1 (insulin-dependent) diabetic patients with and without clinical nephropathy: a light microscopic, morphometric study of autopsy material","volume":"26","author":"Thomsen","year":"1984","journal-title":"Diabetologia"},{"issue":"2\u20133","key":"10.1016\/j.diabres.2014.10.014_bib0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0344-0338(11)80780-6","article-title":"The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis","volume":"187","author":"Bohle","year":"1991","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.diabres.2014.10.014_bib0095","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/diab.43.8.1046","article-title":"Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria","volume":"43","author":"Taft","year":"1994","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2014.10.014_bib0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ki.2013.490","article-title":"Microalbuminuria: target for renoprotective therapy PRO","volume":"86","author":"Roscioni","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.10.014_bib0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","article-title":"Albuminuria reflects widespread vascular damage. The Steno hypothesis","volume":"32","author":"Deckert","year":"1989","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.diabres.2014.10.014_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00125-005-0077-3","article-title":"Prediction, progression and prevention of diabetic nephropathy. The Minkowski lecture 2005","volume":"49","author":"Rossing","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2014.10.014_bib0115","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.1997.00440340025002","article-title":"The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus","volume":"157","author":"Dinneen","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabres.2014.10.014_bib0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s001250050983","article-title":"Renoprotection in diabetes: genetic and non-genetic risk factors and treatment","volume":"41","author":"Parving","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2014.10.014_bib0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2014.10.014_bib0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2337\/diacare.29.02.06.dc05-1242","article-title":"Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy","volume":"29","author":"Astrup","year":"2006","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2014.10.014_bib0135","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2337\/diacare.28.9.2255","article-title":"Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study","volume":"28","author":"Giunti","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.10.014_bib0140","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/0140-6736(93)90816-Y","article-title":"Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes","volume":"341","author":"Wang","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2014.10.014_bib0305","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.1016\/j.diabres.2014.10.014_bib0310","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group\/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342:381-9.","DOI":"10.1056\/NEJM200002103420603"},{"issue":"7258","key":"10.1016\/j.diabres.2014.10.014_bib0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Br Med J"},{"issue":"15","key":"10.1016\/j.diabres.2014.10.014_bib0160","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.10.014_bib0165","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.10.014_bib0315","doi-asserted-by":"crossref","unstructured":"The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-59.","DOI":"10.1056\/NEJMoa0802743"},{"issue":"2","key":"10.1016\/j.diabres.2014.10.014_bib0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diabres.2014.10.014_bib0180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.2012.401","article-title":"Intensive glucose control improves kidney outcomes in patients with type 2 diabetes","volume":"83","author":"Perkovic","year":"2013","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.diabres.2014.10.014_bib0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinternmed.2011.2230","article-title":"Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes","volume":"172","author":"Coca","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabres.2014.10.014_bib0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(97)06209-0","article-title":"Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes","volume":"351","author":"Chaturvedi","year":"1998","journal-title":"Lancet"},{"issue":"9647","key":"10.1016\/j.diabres.2014.10.014_bib0195","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","article-title":"Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials","volume":"372","author":"Chaturvedi","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.diabres.2014.10.014_bib0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.10.014_bib0320","doi-asserted-by":"crossref","unstructured":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355:253-9.","DOI":"10.1016\/S0140-6736(99)12323-7"},{"issue":"19","key":"10.1016\/j.diabres.2014.10.014_bib0210","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N Engl J Med"},{"issue":"9590","key":"10.1016\/j.diabres.2014.10.014_bib0215","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.diabres.2014.10.014_bib0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/0003-4819-151-1-200907070-00120","article-title":"Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials","volume":"151","author":"Bilous","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.diabres.2014.10.014_bib0225","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.10.014_bib0325","doi-asserted-by":"crossref","unstructured":"* ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 2001; 134(5):370-9.","DOI":"10.7326\/0003-4819-134-5-200103060-00009"},{"key":"10.1016\/j.diabres.2014.10.014_bib0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.319.7201.24","article-title":"Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria","volume":"319","author":"Mathiesen","year":"1999","journal-title":"Br Med J"},{"key":"10.1016\/j.diabres.2014.10.014_bib0240","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-118-8-199304150-00001","article-title":"Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients","volume":"118","author":"Ravid","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2014.10.014_bib0330","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. Br Med J 1998; 317(7160):713-20.","DOI":"10.1136\/bmj.317.7160.713"},{"key":"10.1016\/j.diabres.2014.10.014_bib0250","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 Diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diabres.2014.10.014_bib0255","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/diacare.26.3.569","article-title":"Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in patients with type 2 diabetes and microalbuminuria study","volume":"26","author":"Rossing","year":"2003","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2014.10.014_bib0260","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.2337\/diacare.26.12.3296","article-title":"Kidney function during and after withdrawal of long-term irbesartan treatment in patients with type 2 diabetes and microalbuminuria","volume":"26","author":"Andersen","year":"2003","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2014.10.014_bib0265","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2337\/dc11-0324","article-title":"Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial","volume":"34","author":"Hellemons","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2014.10.014_bib0270","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/ndt\/gfh470","article-title":"Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria","volume":"19","author":"Gaede","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2014.10.014_bib0335","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 2014; 37(Suppl 1):S14-S80.","DOI":"10.2337\/dc14-S014"},{"issue":"9153","key":"10.1016\/j.diabres.2014.10.014_bib0280","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2014.10.014_bib0285","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.diabres.2014.10.014_bib0290","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00125-014-3330-9","article-title":"Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies","volume":"57","author":"Schmieder","year":"2014","journal-title":"Diabetologia"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822714004744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822714004744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:06:08Z","timestamp":1759172768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822714004744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0168822714004744"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2014.10.014","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microalbuminuria: A parameter that has changed diabetes care","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2014.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}